Perhaps one of the greatest quests throughout the ages has been in trying to discover that elusive “fountain of youth.” What if, however, the answer lies in a simple, generic medication already widely available, with the potential to extend human life to as much as 120 years?
Believe it or not, the FDA has recently approved a first clinical trial of metformin as a medication to slow the aging process. The Targeting Aging with Metformin (TAME) study is, at this point, held back by one crucial element: funding. With a projected price tag of $65 million to facilitate the 6-year study of 3,000 volunteers, it’s a gamble none of the big pharma companies have yet been willing to wager.
An even bigger consideration may be whether we, as a society, consider aging to be a disease in need of a cure; or, if it’s possible to embrace aging for the benefits it inherently offers: a lifetime of achievements, lessons learned, wisdom gained, and relationships forged.
At Responsive Home Care, we cherish and value each of the individuals in our care, regardless of age, and are devoted to celebrating the joys we discover together in each new day!